Medicus Pharma Signs 6-Part National Media Series With New to The Street | NewsOut

Biotech and healthcare investors: New to The Street has signed a six-part media series with Medicus Pharma, a precision-guided biotechnology company advancing novel therapeutic assets and clinical development programs.

Reporting from the New York Stock Exchange, Jane King explains the multi-channel campaign is designed to increase visibility among institutional investors, analysts, and the life sciences community, highlighting Medicus Pharma’s clinical progress, leadership strategy, and long-term growth opportunities.

#MedicusPharma
#BiotechNews
#ClinicalDevelopment
#LifeSciences
#HealthcareInvesting
#NewToTheStreet
#InvestorRelations
#MediaSeries
#PharmaceuticalInnovation
#JaneKing
#NewsOut
#NYSE